extrahepatic metastasis
Showing 1 - 25 of 1,937
Hepatocellular Carcinoma Trial in Guangzhou (Systemic chemo, Lenvatinib, Toripalimab)
Recruiting
- Hepatocellular Carcinoma
- Systemic chemotherapy
- +2 more
-
Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
Feb 19, 2021
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Extrahepatic Bile Duct Cancer, Pancreatic Cancer, Lymph Node Metastases Trial in Suwon (Two-in-one stent)
Recruiting
- Extrahepatic Bile Duct Cancer
- +3 more
- Two-in-one stent
-
Suwon, Gyeong Gi Do, Korea, Republic of
- +1 more
Jul 20, 2021
Hepatocellular Carcinoma Trial (Hepatectomy Combined With Camrelizumab and Apatinib)
Recruiting
- Hepatocellular Carcinoma
- Hepatectomy Combined With Camrelizumab and Apatinib
-
Nanning, ChinaGuangxi Medical University Cancer Hospital
Sep 4, 2022
Cholangiocarcinoma, Biliary Tract Cancer, Adjuvant Chemo Trial in Seoul (Gemcitabine plus cisplatin, Capecitabine)
Recruiting
- Cholangiocarcinoma
- +5 more
- Gemcitabine plus cisplatin
- Capecitabine
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 13, 2020
Hepatocellular Carcinoma Trial in Guangzhou (Ronvatinib + sindillimab, radiofrequency ablation)
Not yet recruiting
- Hepatocellular Carcinoma
- Ronvatinib + sindillimab
- radiofrequency ablation
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital, Sun Yat-Sen University
Apr 5, 2023
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial
Not yet recruiting
- Hepatocellular Carcinoma
- +3 more
- (no location specified)
Feb 21, 2023
Hepatocellular Carcinoma Trial in Hong Kong (Radiofrequency ablation or microwave ablation)
Recruiting
- Hepatocellular Carcinoma
- Radiofrequency ablation or microwave ablation
-
Hong Kong, Hong KongChinese University of Hong Kong
Feb 27, 2022
Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer Trial in Amsterdam (Neoadjuvant systemic therapy (CAPOX+/-B
Recruiting
- Colorectal Cancer
- +5 more
- Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
- Repeat local treatment
-
Amsterdam, NetherlandsAmsterdam UMC
May 5, 2023
ColoRectal Cancer, Liver Metastasis Colon Cancer, Liver Metastases Trial in Amsterdam (Thermal ablation, Surgical resection)
Recruiting
- ColoRectal Cancer
- +3 more
- Thermal ablation
- Surgical resection
-
Amsterdam, NH, NetherlandsAmsterdam University Medical Center - location VUmc
Dec 18, 2022
Colorectal Cancer, Liver Metastases, Genetic Change Trial in Barcelona (Liver transplantation)
Recruiting
- Colorectal Cancer
- +2 more
- Liver transplantation
-
Barcelona, SpainDepartment of HPB Surgery and Transplants, Hospital Vall d´Hebro
Jun 13, 2022
Hepatocellular Carcinoma Trial in Guangzhou (TACE(Transcatheter arterial chemoembolization), Lenvatinib)
Recruiting
- Hepatocellular Carcinoma
- TACE(Transcatheter arterial chemoembolization)
- Lenvatinib
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 17, 2022
Hepatocellular Carcinoma Trial in China (Anlotinib HCl capsules, Penpulimab injection, Anlotinib HCl capsules -matching ,
Recruiting
- Hepatocellular Carcinoma
- Anlotinib hydrochloride capsules, Penpulimab injection
- Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo
-
Bengbu, Anhui, China
- +66 more
May 15, 2023
Colorectal Liver Metastasis Trial in Germany (Resection of colorectal liver metastases)
Recruiting
- Colorectal Liver Metastasis
- Resection of colorectal liver metastases
-
Mannheim, Baden-Württemberg, Germany
- +10 more
Jul 13, 2022
Hepatocellular Carcinoma Trial in Guangzhou (digital subtraction angiography., FOLFOX (oxaliplatin , leucovorin , fluorouracil ,
Recruiting
- Hepatocellular Carcinoma
- digital subtraction angiography.
- FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
Feb 7, 2023
Disseminated Pancreatic Cancer Trial in Linköping (Liver resection (ablation))
Not yet recruiting
- Disseminated Pancreatic Cancer
- Liver resection (ablation)
-
Linköping, SwedenLinkoping University Hospital
Feb 26, 2022
OREIOS International Study
Recruiting
- Hepatocellular Carcinoma
-
Alexandira, Egypt
- +21 more
Jan 11, 2023
Donafenib Combined With TACE-based Treatment in Unresectable HCC
Recruiting
- Hepatocellular Carcinoma
- Donafenib
- Donafenib combined with TACE
-
Shanghai, ChinaFudan University
Mar 21, 2022
Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer Trial (Stereotactic Body Radiotherapy, Microwave Ablation)
Recruiting
- Colorectal Cancer Metastatic
- Liver Metastasis Colon Cancer
- Stereotactic Body Radiotherapy
- Microwave Ablation
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC
Dec 18, 2022
Colorectal Liver Metastases Trial in Beijing (Tislelizumab, Regorafenib, HAIC)
Recruiting
- Colorectal Liver Metastases
- Tislelizumab
- +2 more
-
Beijing, Beijing, China
- +1 more
May 25, 2023
HCC Trial in China (DEB-TACE and HAIC, DEB-TACE)
Recruiting
- HCC
- DEB-TACE and HAIC
- DEB-TACE
-
Luohe, Henan, China
- +15 more
Mar 28, 2023
Non-invasive Dual-Pet Information in Subtype of Metastatic
Recruiting
- Breast Cancer
- biopsy or surgical pathology in metastases
- 68Ga-HER2 affibody,18F-FDG, 18F-FES
-
Shanghai, Shanghai, ChinaShanghai Cancer Center Institutional Review Board
Apr 19, 2022
Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon
Recruiting
- Unresectable Colorectal Liver Metastases
- Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
-
Nanjing, Jiangsu, ChinaZhongda Hospital Southeast University
Jan 26, 2023
Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Tislelizumab, Ablation)
Recruiting
- Recurrent Hepatocellular Carcinoma
- Tislelizumab
- Ablation
-
Guangzhou, Guangdong, ChinaDepartment of Minimally Invasive and Interventional Radiology, L
May 21, 2021